The comparative effectiveness and cost-effectiveness of vitreoretinal interventions
Authors:
- Melissa M BrownMBMelissa M Brown
- Gary C BrownGBGary C Brown
- Heidi C BrownHBHeidi C Brown
- Blair IrwinBIBlair Irwin
- Kathryn S BrownKBKathryn S Brown
- 1 May 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 19 (3) , 202-207
Abstract
The comparative effectiveness of medical interventions has recently been emphasized in the literature, typically for interventions in a similar class. Value-based medicine, the practice of medicine based on the value (improvement in quality of life and/or length of life) conferred by medical interventions, allows a measure of comparative effectiveness of interventions across all of health care, no matter how disparate. This report discusses recent comparative effectiveness studies in the vitreoretinal literature. Vitreoretinal interventions have good to excellent comparative effectiveness compared with commonly utilized interventions across health care, such as treatment for osteoporosis and hyperlipidemia. They also tend to be cost-effective when an upper limit of $100 000/quality-adjusted life-year is utilized. Value can be measured using either or both of two outcomes - the quality-adjusted life-year gain and/or the percentage improvement in value - both of which allow for an evaluation of comparative effectiveness, which can be compared on the same scale for every intervention. This value can also be integrated with costs using the outcome of dollars expended per quality-adjusted life-year ($/quality-adjusted life-year, or the cost-utility ratio), which allows a comparison of cost-effectiveness across all interventions. The majority of vitreoretinal interventions confer considerable value and are cost-effective.Keywords
This publication has 20 references indexed in Scilit:
- A Value-Based Medicine Comparison of Interventions for Subfoveal Neovascular Macular DegenerationOphthalmology, 2007
- Cost-utility analysis of cataract surgery in the second eyeOphthalmology, 2003
- CME REVIEWRetina, 2003
- Validity of the time trade-off and standard gamble methods of utility assessment in retinal patientsBritish Journal of Ophthalmology, 2002
- The cost-effectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathyCurrent Opinion in Ophthalmology, 2001
- Utility values associated with blindness in an adult populationBritish Journal of Ophthalmology, 2001
- INCREMENTAL COST-EFFECTIVENESS OF LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH HISTOPLASMOSISRetina, 2000
- INCREMENTAL COST-EFFECTIVENESS OF LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH HISTOPLASMOSISRetina, 2000
- What is heartburn worth?Journal of General Internal Medicine, 2000
- Utility Values and Age-related Macular DegenerationArchives of Ophthalmology (1950), 2000